Fatigue Outcomes of Copaxone Users in Relapsing-remitting Multiple Sclerosis.

Trial Profile

Fatigue Outcomes of Copaxone Users in Relapsing-remitting Multiple Sclerosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Glatiramer acetate (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms FOCUS
  • Sponsors Sanofi
  • Most Recent Events

    • 01 Oct 2008 Actual end date (Oct 2006) added as reported by ClinicalTrials.gov.
    • 01 Oct 2008 Actual patient number (111) added as reported by ClinicalTrials.gov.
    • 01 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top